Zobrazeno 1 - 10
of 37
pro vyhledávání: '"P, Cataruozolo"'
Autor:
Reza Khosravan, P Cataruozolo, Aron Goldhirsch, Javer Cortés, Anthony D. Elias, Xin Huang, Kenneth A. Kern, Mary Collier, Rossano Cesari, Xavier Pivot, Giuseppe Curigliano
Publikováno v:
The Breast. 22:650-656
Purpose This randomized, open-label phase II study compared the efficacy of sunitinib monotherapy with that of single-agent standard-of-care (SOC) chemotherapy in patients with previously treated advanced triple-negative breast cancer (TNBC). Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0709dc4bfee87ff81d98b3a54188d498
https://doi.org/10.1016/j.breast.2013.07.037
https://doi.org/10.1016/j.breast.2013.07.037
Autor:
P Cataruozolo, Rossano Cesari, Kenneth A. Kern, J. Cortes, Anthony D. Elias, Xin-Yun Huang, Mary Collier, Xavier Pivot, Aron Goldhirsch, Giuseppe Curigliano
Publikováno v:
Cancer Research. 70:P6-12
Background Triple-negative (TN) breast cancer (BC), which comprises approximately 15% of all BC cases, has a particularly poor prognosis. In a phase II study in patients with heavily pretreated metastatic BC, 15% of patients (3/20) with TN disease ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b14b40c149ae5ba852c2aa24bad0378
https://doi.org/10.1158/0008-5472.sabcs10-p6-12-02
https://doi.org/10.1158/0008-5472.sabcs10-p6-12-02
Autor:
P Cataruozolo, Kathy D. Miller, L. Verkh, P. A. Gowland, Xin-Yun Huang, A. Starr, E. Chuang, Mary Collier, Mark Kozloff, Kenneth A. Kern
Publikováno v:
Annals of Oncology
Background: Sunitinib has shown single-agent activity in patients with previously treated metastatic breast cancer (MBC). We investigated the safety of the combination of sunitinib and paclitaxel in an exploratory study of patients with locally advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcaf19fea0bc5949d80394b37d0acc55
http://europepmc.org/articles/PMC2890319
http://europepmc.org/articles/PMC2890319
Autor:
P A, Gross, P, Cataruozolo, W, Mitofsky, M, Furnari, T, Crupi, J H, Skurnick, P, DeMauro, G, Statmore, M, Moogan, J, Berdy, C, Sokol
Publikováno v:
Clinical performance and quality health care. 7(2)
Implementation of preventive services guidelines is performed inconsistently. In an attempt to reduce variation in guideline implementation, we developed a patient questionnaire based on the US Preventive Services Task Force Guide and the Health Plan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0b5e70868e7265c9c21d2ce32895b81
https://pubmed.ncbi.nlm.nih.gov/10747565
https://pubmed.ncbi.nlm.nih.gov/10747565
Autor:
P Cataruozolo, Peter A. Gross, Sandy Dran, Armen Donabedian, Steven J. Sperber, Gail Morchel, Gary Munk
Publikováno v:
Vaccine. 17(18)
Background: repeated influenza immunization does not appear to adversely affect the serum antibody response to new influenza strains. Objective: to determine whether the immune response to a new influenza strain was inferior in persons previously vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845c52788a711a4d053bd53ce5423e8f
https://pubmed.ncbi.nlm.nih.gov/10403596
https://pubmed.ncbi.nlm.nih.gov/10403596
Publikováno v:
Clinical performance and quality health care. 5(4)
Severity adjustment is an oft-cited requirement when comparing physicians or medical delivery systems. Each application of severity adjustment, however, has to be tested to validate the need, the method, and its value. We examined the value of severi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22ab39672ee2ddec36677b5cba8b21d4
https://pubmed.ncbi.nlm.nih.gov/10176025
https://pubmed.ncbi.nlm.nih.gov/10176025
The earliest time at which serum antibody levels peak following administration of an influenza virus vaccine in elderly persons is not clearly defined. We compared the time intervals of 1 and 2 weeks after vaccination. A commercial trivalent vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288bc69c788a8d1e4cd917b0fcbc73d5
https://europepmc.org/articles/PMC170557/
https://europepmc.org/articles/PMC170557/
Autor:
Gary Monk, Mary Vassallo, Sandra Dran, Peter A. Gross, Maureen Bernius, Pureza F. Gaerlan, Roland Levandowski, Sylvan Wallenstein, P Cataruozolo, Gerald V. Quinnan, Joan Bonelli, Carolyn R. Denning
Publikováno v:
Vaccine. 14(13)
Objective: To determine the effect of repeated annual influenza immunization on the host's serum antibody. Design: Ten year observational study with cohort design. Setting: Cystic Fibrosis Center at St. Vincent's Hospital and Medical Center, New York
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::856b42c5ce6b241ce1d8f7edfcb8ac41
https://pubmed.ncbi.nlm.nih.gov/8961518
https://pubmed.ncbi.nlm.nih.gov/8961518
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.